Skip to content

ASSESSMENT OF SHEARWAVE? ELASTOGRAPHY IN THE ULTRASONIC DETECTION AND DIAGNOSIS OF BREAST CANCER IN CHINESE PATIENTS

ASSESSMENT OF SHEARWAVE? ELASTOGRAPHY IN THE ULTRASONIC DETECTION AND DIAGNOSIS OF BREAST CANCER IN CHINESE PATIENTS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14004785
Enrollment
Unknown
Registered
2014-06-08
Start date
2014-06-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Mass

Interventions

Gold Standard:
Index test:

Sponsors

Cancer Hospital Affiliated to Shanghai Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Female aged 18 years old or more; Have been referred to a breast ultrasound because of a known breast mass or suspicion of a breast lesion.

Exclusion criteria

Exclusion criteria: 1. Women who are unwilling or unable to provide informed consent; 2. Women with breast implants; 3. Women who are pregnant or breastfeeding; 4. Women who are undergoing chemotherapy or radiotherapy for any cancer; 5. Women in whom all lesions are diagnostically categorized as BI-RADS 0, 1 or 6; 6. Women in whom the lesion under investigation has been previously biopsied; 7. Women with previous ipsilateral breast surgery; 8. Women with no visible breast mass on ultrasound examination; 9. Women with axillary metastatic lymph nodes only; 10. Women with foreign body in the breast.

Design outcomes

Primary

MeasureTime frame
Longest dimension of mass in SWE mode;Hardest Young's Module of mass;Ratio of Young's Module of mass;Sd of Young's Module of mas;

Countries

China

Contacts

Public ContactJoel Gay

SuperSonic Imagine

joel.gay@supersonicimagine.com+33 (0)486 790 313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026